/

Rongrong Wu1, Xinyang Hu2, Jian'an Wang2

  • 1Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, PR China; State Key Laboratory of Transvascular Implantation Devices, Hangzhou 310009, PR China; Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou 310009, PR China.

概括

来自干细胞的细胞外囊泡 (EVs),特别是外体,显示出治疗缺血性心脏病的前景. 优化它们的生产和设计以更好地提供它们是临床成功的关键.